Type 1 Hyperlipoproteinemia
1 clinical trials · Condition
◉ Watch Type 1 Hyperlipoproteinemia
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia (NCT01675154) | University of Texas Southwestern Medical Center | 2015-11-01 |
Track Type 1 Hyperlipoproteinemia automatically
Every clearance here is in the API, with alerts when new ones post.